Immuron (IMRN) Cost of Revenue (2016 - 2024)

Immuron's Cost of Revenue history runs 9 years deep, the most recent figure standing at -$874530928.1 billion for Q4 2024.

• On a quarterly basis, Cost of Revenue fell 112808930498813.45% year-over-year to -$874530928.1 billion in Q4 2024; TTM through Dec 2024 was -$874530928.1 billion, a 92466917849144.55% decrease from a year earlier, with the FY2025 full-year figure at $312370.5, down 69.59% from the prior year.
• Cost of Revenue eased to -$874530928.1 billion in Q4 2024 per IMRN's latest filing, from $775232.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $775232.0 in Q4 2023 and bottomed at -$874530928.1 billion in Q4 2024.
• The 5-year median for Cost of Revenue is $7409.5 (2021), against an average of -$145755154.7 billion.
• Across the five-year window, Cost of Revenue surged 5568778.93% in 2021 and plunged 112808930498813.45% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $0.01 in 2020, then jumped by 5568778.93% to $508.16 in 2021, then soared by 30545.09% to $155726.0 in 2022, then jumped by 397.82% to $775232.0 in 2023, then plunged by 112808930498813.45% to -$874530928.1 billion in 2024.
• Per Business Quant, the three latest IMRN Cost of Revenue figures stand at -$874530928.1 billion (Q4 2024), $775232.0 (Q4 2023), and $14310.9 (Q2 2023).